Emerging Pathogens vaccines
I am a Postdoctoral Immunologist working with Dr Teresa Lambe in the Emerging Pathogens Vaccine Programme with particulate interest in immune response towards Crimean-Congo Haemorrhagic Fever Virus (CCHFV) and other Nairoviruses to aid effective vaccine design.
Before joining the Jenner Institute, I obtained my MSc degree in Biology at the University of Belgrade, where I was working for several years as a research assistant on different scientific projects in the area of Immunotoxicology. I completed my PhD at the Medical University of Vienna where I worked in the area of Vaccine Development on the project with a strong emphasis on constructing a mucosal vaccine candidate and appropriate adjuvants for prevention of the neglected ocular surface disease trachoma, caused by Chlamydia trachomatis.
Oral warfarin affects some aspects of systemic immunomodulation with topical dinitrochlorobenzene (DNCB) in rats
Popov Aleksandrov A. et al, (2018), Cutaneous and Ocular Toxicology, 37, 29 - 35
The effect of infectious dose on humoral and cellular immune responses in Chlamydophila caviae primary ocular infection
Filipovic A. et al, (2017), PLOS ONE, 12, e0180551 - e0180551
Infectious dose and repeated infections are key factors influencing immune response characteristics in guinea pig ocular chlamydial infection
Belij-Rammerstorfer S. et al, (2016), Microbes and Infection, 18, 254 - 262
Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers
Inic-Kanada A. et al, (2015), PLOS ONE, 10, e0144380 - e0144380